Ledger.Open graph →
SEC Form D · filed August 28, 2018

Chase Therapeutics Corp

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Kathleen N. Clarence-Smith · Washington, Washington, D.C.DirectorJames D. Lanshe · Lakeway, TXExec · DirectorVaibhav Kumar · NEW YORK, NYExecPantas Sutardja · Campbell, CAExec · DirectorShawn Horwitz · Woodland Hills, CAExecVasily Andreev · Pacifica, CADirectorKaroly P. Nikolich · Washington, Washington, D.C.DirectorJohn P. Reher · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗